Bevacizumab for the Treatment of Corneal Neovascularization

Clinical trial NCT00992849 · UNKNOWN

Trial details

NCT number: NCT00992849
Sponsor: Chang Gung Memorial Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Corneal Neovascularization

Start date: 2009-05-01
Primary completion: 2010-04-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.